The evolution of oesophageal function testing and its clinical applications in the management of patients with oesophageal disorders

Motilidade esofágica após derivação gástrica em Y-de-Roux para obesidade mórbida: achados à manometria de alta resolução

RACIONAL:A cirurgia bariátrica pode provocar alterações na motilidade esofágica. Entretanto, existe paucidade de estudos com a manometria de alta resolução. OBJETIVO: Avaliar a motilidade esofágica em pacientes submetidos à derivação gástrica em Y-de-Roux para obesidade mórbida. MÉTODOS: Foram estudados 18 pacientes assintomáticos submetidos à derivação gástrica em Y-de-Roux por laparotomia. Todos foram submetidos à manometria de alta resolução em média três anos após a operação. RESULTADOS: O esfíncter esofagiano inferior teve pressão basal média de 18±13 (variação 0-51) mmHg; sete pacientes (39%) apresentaram hipotonia e um (5%) hipertonia. O relaxamento foi anormal em um paciente. O comprimento total e abdominal do esfíncter foi de 4±1 (1-7) cm e 2±1 (0-3) cm, respectivamente. A amplitude distal do corpo esofágico (média de 3 e 7 cm acima do esfíncter) foi de 77±22 (40-120) mmHg e um paciente (5%) teve hipocontratilidade. Ondas peristálticas foram vistas em 95±0% (60-100). O esfíncter esofagiano superior tinha pressão basal média de 118±82 (33 - 334) mmHg; um (5%) paciente apresetnou hipotonia e oito (44%) hipertonia. CONCLUSÃO: Após a derivação gástrica, ocorreu significante hipotonia do esfíncter esofágico inferior e hipertonia do esfíncter esofágico superior.

Critical analysis of esophageal multichannel intraluminal impedance monitoring 20 years later

Multichannel intraluminal impedance (MII) for the evaluation of esophageal diseases was created in 1991 trying to solve previous limitations of esophageal function test. MII-pH is able to determine the physical characteristics of the refluxate (liquid, gas, or mixed) and nonacidic GER. MII-manometry can determine the presence of bolus and its relation with peristalsis. This paper makes a critical analysis of the clinical applications of MII 20 years after its creation. Literature review shows that MII made great contributions for the understanding of esophageal physiology; however, direct clinical applications are few. MII-pH was expected to identify patients with normal acid reflux and abnormal nonacidic reflux. These patients are rarely found off therapy, that is, nonacidic reflux parallels acid reflux. Furthermore, the significance of isolated nonacidic reflux is unclear. Contradictory MII-manometry and conventional manometry findings lack better understanding and clinical implication as well as the real significance of bolus transit.

Achalasia cardia subtyping by high-resolution manometry predicts the therapeutic outcome of pneumatic balloon dilatation

BACKGROUND/AIMS

High-resolution manometry (HRM) with pressure topography is used to subtype achalasia cardia, which has therapeutic implications. The aim of this study was to compare the clinical characteristics, manometric variables and treatment outcomes among the achalasia subtypes based on the HRM findings.

METHODS

The patients who underwent HRM at the Asian Institute of Gastroenterology, Hyderabad between January 2008 and January 2009 were enrolled. The patients with achalasia were categorized into 3 subtypes: type I - achalasia with minimum esophageal pressurization, type II - achalasia with esophageal compression and type III - achalasia with spasm. The clinical and manometric variables and treatment outcomes were compared.

RESULTS

Eighty-nine out of the 900 patients who underwent HRM were diagnosed as achalasia cardia. Fifty-one patients with a minimum follow-up period of 6 months were included. Types I and II achalasia were diagnosed in 24 patients each and 3 patients were diagnosed as type III achalasia. Dysphagia and regurgitation were the main presenting symptoms in patients with types I and II achalasia. Patients with type III achalasia had high basal lower esophageal sphincter pressure and maximal esophageal pressurization when compared to types I and II. Most patients underwent pneumatic dilatation (type I, 22/24; type II, 20/24; type III, 3/3). Patients with type II had the best response to pneumatic dilatation (18/20, 90.0%) compared to types I (14/22, 63.3%) and III (1/3, 33.3%).

CONCLUSIONS

The type II achalasia cardia showed the best response to pneumatic dilatation.